Alembic Pharma gets five observations from USFDA for Gujarat facility

As per the USFDA, a Form 483 is issued to a firm's management at the
conclusion of an inspection when an investigator has observed any
conditions that in its judgment may constitute violations of the Food
Drug and Cosmetic (FD&C) Act and related Acts.

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/alembic-pharma-gets-five-observations-from-usfda-for-gujarat-facility/articleshow/80745383.cms

Comments

Popular posts from this blog

Pharma Production Executive Post Vacancy @ Intas

Pharos of Chaos

HILR Intersession: Mollie Crawford-Volk: Velazquez' "Las Meninas" and its Modern Progeny